Comparison

(S)-Afatinib European Partner

Item no. TMO-T2303-2mg
Manufacturer TargetMol
CASRN 439081-18-2
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 g 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 1
Citations 1. Prim N, et al. Rev Pneumol Clin. 2014 Oct;70(5):279-85.
Smiles CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias BIBW2992
Shipping Condition Cool pack
Available
Manufacturer - Targets
HER|||EGFR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
485.94
Description
(S)-Afatinib (BIBW2992) is an irreversible EGFR family inhibitor with IC50s of 0.5/0.4/10/14/1 nM for EGFRwt, EGFR (L858R), EGFR (L858R/T790M), HER2, and HER4, respectively.
Pathways
Angiogenesis|||Tyrosine Kinase/Adaptors|||JAK/STAT signaling
Bioactivity
Afatinib is a tyrosine kinase receptor inhibitor that is used in the therapy of selected forms of metastatic non-small cell lung cancer.
Receptor
EGFR (L858R); EGFR (L858R/T790M); EGFR (wt); HER2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close